Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
8.66
+0.24 (2.81%)
Sep 3, 2025, 4:00 PM - Market closed
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $414.97 million as of September 3, 2025. Its market cap has increased by 68.36% in one year.
Market Cap
414.97M
Enterprise Value
416.33M
1-Year Change
68.36%
Ranking
Category
Stock Price
$8.66
Market Cap Chart
Since the IPO on November 21, 2016, Nanobiotix's market cap has increased from $249.91M to $414.97M, an increase of 66.05%. That is a compound annual growth rate of 5.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 414.97M | 179.61% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | 581.15M | 179.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |